Product Description
Since last many years Saintroy Life science is leading manufacture, export and supplier of Artesunate + Amodiaquine tablets from Surat, Gujarat, India. Artesunate +Amodiaquine tablets used for the treatment of malaria. It is a fixed-dosecombination of artesunate and amodiaquine.
Tags: Artesunate + Amodiaquine tablets manufacturer ,Artesunate + Amodiaquine tablets exporter, Artesunate + Amodiaquine tablets supplier ,and Artesunate + Amodiaquine tablets , who gmp approved Artesunate + Amodiaquinetablets manufacturer and supplier,Artesunate+ Amodiaquine tablets distributor, Artesunate+ Amodiaquine tablets drop shipper, Artesunate+ Amodiaquine tablets 100 mg/ 270mg, Artesunate+ Amodiaquine tablets 100 mg/ 270mg supplier, Artesunate+ Amodiaquine tablets 100 mg/ 270mg.
ISO/GMP/cGMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.
Registration: Saintroy Life science is interested in registration of own brand or customer brands in ministry of health of clients country and we also provide the products samples, COA, COPP, ACTD or CTDD ossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Life science Artesunate +Amodiaquine tablets export to USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal, Sudan, UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe ,Togo, Burkina Faso, Niger, Guinea Bissau, Congo, Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt ,Kyrgyzstan, Uzbekistan, Kazakhstan.
Dual-Action Malaria DefenseBy combining Artesunate and Amodiaquine, these tablets offer a potent approach to malaria treatment. The dual ingredients work together to attack malaria parasites at different life cycle stages, increasing the therapy's effectiveness and reducing the risk of resistance.
Versatile Application and SuitabilityFormulated to suit children, teenagers, and women, Artesunate + Amodiaquine tablets support diverse patient needs. They are a preferred choice for healthcare professionals, exporters, and distributors aiming to provide reliable and wide-ranging malaria care.
FAQ's of Artesunate + Amodiaquine tablets:
Q: How should Artesunate + Amodiaquine tablets be administered?
A: Artesunate + Amodiaquine tablets should be taken as directed by your doctor, who will determine the appropriate dosage based on age, weight, and medical condition.
Q: What are the main ingredients in these anti-malarial tablets?
A: Each tablet contains 100 mg of Artesunate and 270 mg of Amodiaquine, offering a strong combination therapy against malaria.
Q: When is it advisable to use Artesunate + Amodiaquine tablets?
A: These tablets are used when a patient is diagnosed with malaria, particularly where resistant strains are suspected or confirmed, under medical supervision.
Q: Where should I store this medication for optimal efficacy?
A: Store the tablets in a cool and dry place, away from direct sunlight and moisture, as recommended by your physician and on the packaging.
Q: What is the process for distributing or exporting these tablets in India?
A: Dealers, distributors, exporters, and suppliers must comply with local regulations for pharmaceutical products and coordinate with registered manufacturers and wholesalers to ensure safe distribution.
Q: How does this medicine benefit children and women?
A: Formulated for safety and efficacy, the combination targets malaria effectively while accommodating dosing needs for children and women, under a doctor's guidance.
Q: Is there any specific usage guideline for taking these tablets?
A: Always follow the dosage prescribed by your healthcare provider, complete the full course, and never self-medicate or adjust the dose without consulting a doctor.